BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yang M, Xu W, Bittner H, Horsington J, Vosloo W, Goolia M, Lusansky D, Nfon C. Generation of mAbs to foot-and-mouth disease virus serotype A and application in a competitive ELISA for serodiagnosis. Virol J 2016;13:195. [PMID: 27894355 DOI: 10.1186/s12985-016-0650-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Wong CL, Yong CY, Ong HK, Ho KL, Tan WS. Advances in the Diagnosis of Foot-and-Mouth Disease. Front Vet Sci 2020;7:477. [PMID: 32974392 DOI: 10.3389/fvets.2020.00477] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Jeong S, Ahn HJ, Min KJ, Byun JW, Pyo HM, Park MY, Ku BK, Nah J, Ryoo S, Wee SH, Kim SJ. Phage Display Screening of Bovine Antibodies to Foot-and-Mouth Disease Virus and Their Application in a Competitive ELISA for Serodiagnosis. Int J Mol Sci 2021;22:4328. [PMID: 33919326 DOI: 10.3390/ijms22094328] [Reference Citation Analysis]
3 Nguyen QT, Yang J, Byun JW, Pyo HM, Park MY, Ku BK, Nah J, Ryoo S, Wee SH, Choi KS, Poo H. Development of Monoclonal Antibody Specific to Foot-and-Mouth Disease Virus Type A for Serodiagnosis. Pathogens 2019;8:E301. [PMID: 31861046 DOI: 10.3390/pathogens8040301] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
4 Wang J, Chen J, Zhang S, Ding Y, Wang M, Zhang H, Liang R, Chen Q, Niu B. Risk assessment and integrated surveillance of foot-and-mouth disease outbreaks in Russia based on Monte Carlo simulation. BMC Vet Res 2021;17:268. [PMID: 34376207 DOI: 10.1186/s12917-021-02967-x] [Reference Citation Analysis]
5 Cao Y, Li K, Xing X, Zhu G, Fu Y, Bao H, Bai X, Sun P, Li P, Zhang J, Ma X, Wang J, Zhao Z, Li D, Liu Z, Lu Z. Development and Validation of a Competitive ELISA Based on Bovine Monoclonal Antibodies for the Detection of Neutralizing Antibodies against Foot-and-Mouth Disease Virus Serotype A. J Clin Microbiol 2022;:e0214221. [PMID: 35254106 DOI: 10.1128/jcm.02142-21] [Reference Citation Analysis]
6 Ran X, Yang Z, Bai M, Zhang Y, Wen X, Guo H, Sun S. Development and validation of a competitive ELISA based on bacterium-original virus-like particles of serotype O foot-and-mouth disease virus for detecting serum antibodies. Appl Microbiol Biotechnol 2019;103:3015-24. [DOI: 10.1007/s00253-019-09680-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
7 Xu W, Yang M. Genetic variation and evolution of foot-and-mouth disease virus serotype A in relation to vaccine matching. Vaccine 2021;39:1420-7. [PMID: 33526282 DOI: 10.1016/j.vaccine.2021.01.042] [Reference Citation Analysis]
8 Nascimento EJM, Bonaparte MI, Luo P, Vincent TS, Hu B, George JK, Áñez G, Noriega F, Zheng L, Huleatt JW. Use of a Blockade-of-Binding ELISA and Microneutralization Assay to Evaluate Zika Virus Serostatus in Dengue-Endemic Areas. Am J Trop Med Hyg 2019;101:708-15. [PMID: 31392955 DOI: 10.4269/ajtmh.19-0270] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
9 González AS, Guimarães Assmann AL, Romero Ramos CR, Quelopana MM, Aleixo Silva AC, Thomaz-Soccol V. Recombinant mutagenic 3ABC protein and monoclonal antibody for quality-control testing in foot-and-mouth disease vaccines. Antiviral Res 2018;157:93-101. [PMID: 30017995 DOI: 10.1016/j.antiviral.2018.07.002] [Reference Citation Analysis]